Lista de obras -

A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin.

artículo científico publicado en 2017

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

artículo científico publicado en 2017

An H10N8 influenza virus vaccine strain and mouse challenge model based on the human isolate A/Jiangxi-Donghu/346/13.

artículo científico publicado en 2015

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations

artículo científico publicado en 2018

Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice

scientific article published on 05 March 2019

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

artículo científico publicado en 2019

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

artículo científico publicado en 2017

Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate.

artículo científico publicado en 2016

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

artículo científico publicado en 2017

Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.

artículo científico publicado en 2016

Hemagglutinin Receptor Binding of a Human Isolate of Influenza A(H10N8) Virus

artículo científico publicado en 2015

Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice

artículo científico publicado en 2015

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

scientific article published on 17 October 2019

In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen

artículo científico publicado en 2014

Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans

artículo científico publicado en 2014

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies

artículo científico publicado en 2018

Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model

artículo científico

Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine

artículo científico publicado en 2019

Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.

artículo científico publicado en 2015

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses

artículo científico publicado en 2015

Lista de obras de

A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin.

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

An H10N8 influenza virus vaccine strain and mouse challenge model based on the human isolate A/Jiangxi-Donghu/346/13.

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations

Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate.

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.

Hemagglutinin Receptor Binding of a Human Isolate of Influenza A(H10N8) Virus

Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen

Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies

Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model

Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine

Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses